Sponsor

Military Institute od Medicine National Research Institute

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Military Institute od Medicine National Research Institute appears in 20 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials20
Recruiting shown2
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

20 shown
Aqueous Humor and Ocular Tissue Analysis in Glaucoma and CataractNCT07462000 · lead sponsor · 2026-01-21
RECRUITING
Radiation-induced Cardiac Toxicity After Non-small Cell Lung Cancer RadiotherapyNCT04867564 · lead sponsor · 2021-05-01
UNKNOWN
New Model of Care in Heart FailureNCT03476590 · lead sponsor · 2018-03-05
COMPLETED
QoL Assessment in Traditional Glaucoma Surgery and MIGS.NCT03613233 · lead sponsor · 2018-01-01
UNKNOWN
Safety and Efficacy of Three Variants of Canaloplasty With Phacoemulsification to Treat Glaucoma and CataractNCT02908633 · lead sponsor · 2016-02-01
UNKNOWN
Comparison of Safety and Efficacy of Hydrus and iStent Combined With Phacoemulsyfication in Open Angle Glaucoma Patients Long-Term Follow-UpNCT07623434 · lead sponsor · 2015-01-01
COMPLETED
Cardiovascular Response to Exercise in HypertensionNCT02634866 · lead sponsor · 2015-01-01
COMPLETED
XEN Glaucoma Implant for the Management of Operated Uncontrolled Glaucoma: Results and Complications During a Long-Term Follow-UpNCT07350200 · lead sponsor · 2014-12-02
COMPLETED
Complex Pathophysiological Background of Heart Failure DeteriorationNCT02355769 · lead sponsor · 2014-12-01
COMPLETED
Non-invasive Haemodynamic Assessment in HypertensionNCT01996085 · lead sponsor · 2013-01-01
COMPLETED
Safety and Efficacy of Canaloplasty and Non-penetrating Deep Sclerectomy With Phacoemulsification to Treat Glaucoma and CataractNCT01726543 · lead sponsor · 2011-02-01
UNKNOWN
Assessment of Effectiveness Ex-Press Surgery ModificationNCT03800589 · lead sponsor · 2010-12-01
COMPLETED
Autonomic Nervous System Activity and Normal Tension GlaucomaNCT01192061 · lead sponsor · 2010-02-01
COMPLETED
The Influence of Induction Anesthetic Agents on Serum Cortisol Concentration in Morbidly Obese Patients.NCT01930019 · lead sponsor · 2009-06-01
COMPLETED
Effect of Adaptive Servoventilation on Cardiac Function in Chronic Heart Failure and Cheyne-Stokes RespirationNCT01212705 · lead sponsor
UNKNOWN
Multimodal Cardiac Imaging Registry in Patients with Atrial FibrillationNCT06584266 · collaborator · 2024-01-01
RECRUITING
The HF-POL Study - Multicenter Study of Polish Patients With HF and LVEF >40%NCT06030661 · collaborator · 2022-01-07
UNKNOWN
Polish Revision Obesity Surgery StudyNCT05108532 · collaborator · 2021-01-01
UNKNOWN
Effect of High Intensity Interval Training on Mechanisms of Neuroplasticity in Parkinson's Disease PatientsNCT04204551 · collaborator · 2018-02-15
UNKNOWN
Ablation of Atrial Fibrillation in Heart Failure PatientsNCT03062241 · collaborator · 2017-01-23
UNKNOWN

Drugs studied in this sponsor's trials

4 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Military Institute od Medicine National Research Institute as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
amlodipine1
lisinopril1
nebivolol1
telmisartan1

Sponsor roles

lead sponsor15
collaborator5
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.